ROPIVACAINE HYDROCHLORIDE
- Product NDC
- 43066-027
- 11-digit product format
- 430660027
- Labeler code
- 43066
- Product ID
- 43066-027_a8d08579-825f-40d9-b1e3-e47b73765ae6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ropivacaine hydrochloride
- Dosage form
- INJECTION
- Route
- EPIDURAL; INFILTRATION; PERINEURAL
- Labeler
- Baxter Healthcare Corporation
- Application
- ANDA212808
- Marketing category
- ANDA
- Marketing start
- 2020-04-09
- Substance
- ROPIVACAINE HYDROCHLORIDE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212808-001 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | |
| A212808-002 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | |
| A212808-003 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | |
| A212808-004 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | |
| A212808-005 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 200MG/100ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | |
| A212808-006 | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | 400MG/200ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212808-001 | AP |
| A212808-002 | AP |
| A212808-003 | AP |
| A212808-004 | AP |
| A212808-005 | AP |
| A212808-006 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A212808-001 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-002 | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-004 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-005 | ROPIVACAINE HYDROCHLORIDE | 200MG/100ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-006 | ROPIVACAINE HYDROCHLORIDE | 400MG/200ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-001 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-002 | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-004 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-005 | ROPIVACAINE HYDROCHLORIDE | 200MG/100ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-006 | ROPIVACAINE HYDROCHLORIDE | 400MG/200ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-001 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-002 | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-004 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-005 | ROPIVACAINE HYDROCHLORIDE | 200MG/100ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-006 | ROPIVACAINE HYDROCHLORIDE | 400MG/200ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-001 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-002 | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-004 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-005 | ROPIVACAINE HYDROCHLORIDE | 200MG/100ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-006 | ROPIVACAINE HYDROCHLORIDE | 400MG/200ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-001 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-002 | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-004 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-005 | ROPIVACAINE HYDROCHLORIDE | 200MG/100ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-006 | ROPIVACAINE HYDROCHLORIDE | 400MG/200ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-001 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-002 | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-004 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-005 | ROPIVACAINE HYDROCHLORIDE | 200MG/100ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-006 | ROPIVACAINE HYDROCHLORIDE | 400MG/200ML (2MG/ML) | SOLUTION / INJECTION | AP | 2024-05-23 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-001 | ROPIVACAINE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-002 | ROPIVACAINE HYDROCHLORIDE | 100MG/20ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-003 | ROPIVACAINE HYDROCHLORIDE | 150MG/30ML (5MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-004 | ROPIVACAINE HYDROCHLORIDE | 200MG/20ML (10MG/ML) | SOLUTION / INJECTION | AP | 2020-04-09 | 2680178bc6a6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A212808-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-003 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-004 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-005 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212808-006 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-003 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-004 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-005 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212808-006 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-003 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-004 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-005 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212808-006 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-003 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-004 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-005 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212808-006 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-003 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-004 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-005 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212808-006 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-002 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-003 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-004 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-005 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212808-006 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-002 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-003 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212808-004 | AP | 1 | 2680178bc6a6… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ROPIVACAINE HYDROCHLORIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ROPIVACAINE HYDROCHLORIDE | 10 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V910P86109 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 387afa15-cb51-403a-b2e2-1c9d201e07dc | Product name | 9 | 20230426 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43066-027-01 | ROPIVACAINE HYDROCHLORIDE | 20 mL in 1 VIAL | INJECTION | 20 | 7 | |
| 43066-027-10 | ROPIVACAINE HYDROCHLORIDE | 10 in 1 CARTON | INJECTION | 10 | 7 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Armas Pharmaceuticals Inc. | 3849f5ce-d077-4318-935d-294be6948142 | 2026-05-20 | Warnings, Adverse reactions | 212808 ANDA212808 |
| ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | SOLA Pharmaceuticals, LLC | 5b3c642b-ab31-45fd-ac0b-b9f6e6cfe3a9 | 2025-12-08 | Warnings, Adverse reactions | 212808 ANDA212808 |
| Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | FRESENIUS KABI USA, LLC | da4a7675-97bf-4d2a-9fdc-c1b4b2999126 | 2025-06-30 | Warnings, Adverse reactions | 212808 ANDA212808 |
| Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Caplin Steriles Limited | a9010ea8-0923-44e4-a7c7-7d65d37d06db | 2025-06-24 | Warnings, Adverse reactions | 212808 ANDA212808 |
| Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | Civica, Inc. | 1fb8e90a-4141-4707-8be6-31f2da5c8fd5 | 2024-11-07 | Warnings, Adverse reactions | 212808 ANDA212808 |
| Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | NorthStar Rx LLC | 61896fe6-4a5a-4e0f-bfc2-44265bc1f2c1 | 2024-01-01 | Warnings, Adverse reactions | 212808 ANDA212808 |
| ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | Baxter Healthcare Corporation | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 2023-06-28 | Warnings, Adverse reactions | 212808 ANDA212808 43066-027 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1734207 | ROPivacaine HCl 0.2 % in 20 ML Injection | PSN | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
| 1734483 | ROPivacaine HCl 0.5 % in 20 ML Injection | PSN | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
| 1734475 | ROPivacaine HCl 0.5 % in 30 ML Injection | PSN | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
| 1734084 | ROPivacaine HCl 1 % in 20 ML Injection | PSN | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
| 1734084 | 20 ML ropivacaine hydrochloride 10 MG/ML Injection | SCD | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
| 1734207 | 20 ML ropivacaine hydrochloride 2 MG/ML Injection | SCD | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
| 1734483 | 20 ML ropivacaine hydrochloride 5 MG/ML Injection | SCD | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
| 1734475 | 30 ML ropivacaine hydrochloride 5 MG/ML Injection | SCD | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
| 1734207 | ropivacaine HCl 0.2 % per 20 ML Injection | SY | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
| 1734483 | ropivacaine HCl 0.5 % per 20 ML Injection | SY | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
| 1734475 | ropivacaine HCl 0.5 % per 30 ML Injection | SY | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
| 1734084 | ropivacaine HCl 1 % per 20 ML Injection | SY | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
| 1734483 | ropivacaine HCl 100 MG per 20 ML Injection | SY | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
| 1734475 | ropivacaine HCl 150 MG per 30 ML Injection | SY | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
| 1734084 | ropivacaine HCl 200 MG per 20 ML Injection | SY | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
| 1734207 | ropivacaine HCl 40 MG per 20 ML Injection | SY | 781d4b7f-7556-4695-8d48-7772d7a0d8e9 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 43066-027-01 | 43066002701 | 20 mL in 1 VIAL | 20 ml | Historical | ||||
| 43066-027-10 | 43066002710 | 10 VIAL in 1 CARTON (43066-027-10) / 20 mL in 1 VIAL (43066-027-01) | 10 vial | 2020-04-09 | 0000-00-00 | No | No | Current |